Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Usana Health Sciences (USNA) over the last 15 years, with Q3 2025 value amounting to $462.5 million.

  • Usana Health Sciences' Non-Current Assets rose 11012.73% to $462.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 billion, marking a year-over-year increase of 11847.11%. This contributed to the annual value of $469.0 million for FY2024, which is 11813.12% up from last year.
  • Usana Health Sciences' Non-Current Assets amounted to $462.5 million in Q3 2025, which was up 11012.73% from $472.7 million recorded in Q2 2025.
  • Over the past 5 years, Usana Health Sciences' Non-Current Assets peaked at $472.7 million during Q2 2025, and registered a low of $90.2 million during Q3 2021.
  • Over the past 5 years, Usana Health Sciences' median Non-Current Assets value was $211.6 million (recorded in 2021), while the average stood at $227.2 million.
  • Data for Usana Health Sciences' Non-Current Assets shows a peak YoY increase of 13681.95% (in 2022) and a maximum YoY decrease of 5661.28% (in 2022) over the last 5 years.
  • Usana Health Sciences' Non-Current Assets (Quarter) stood at $90.7 million in 2021, then skyrocketed by 133.8% to $212.2 million in 2022, then increased by 1.34% to $215.0 million in 2023, then skyrocketed by 118.13% to $469.0 million in 2024, then dropped by 1.38% to $462.5 million in 2025.
  • Its Non-Current Assets stands at $462.5 million for Q3 2025, versus $472.7 million for Q2 2025 and $465.2 million for Q1 2025.